Clinical evaluation of 5-HT3 receptor antagonists as anti-emetics.
Bunce
K
K
Glaxo Group Research Ltd., Ware, Herts, UK.
Tyers
M
M
Beranek
P
P
D000932:Antiemetics / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D009325:Nausea / Q000139:chemically induced / Q000517:prevention & control*; D012702:Serotonin Antagonists
D000932:Antiemetics; D000970:Antineoplastic Agents; D012702:Serotonin Antagonists